CG
GDRX icon

Cutler Group’s GoodRx Holdings GDRX Stock Holding History

Cutler Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,200
Closed -$7K – 3862
2023
Q3 		$7K Buy
10,200
+2,700
+36% +$18K ﹤0.01% 2668
2023
Q2 		$5K Buy
7,500
+1,300
+21% +$7K ﹤0.01% 2616
2023
Q1 		$7K Sell
6,200
-1,100
-15% -$6.13K ﹤0.01% 2542
2022
Q4 		$33K Buy
7,300
+1,600
+28% +$7.88K ﹤0.01% 1858
2022
Q3 		$32K Sell
5,700
-5,700
-50% -$35.9K ﹤0.01% 2240
2022
Q2 		$41K Buy
11,400
+7,000
+159% +$77.9K ﹤0.01% 2096
2022
Q1 		$4K Buy
4,400
+3,600
+450% +$82.6K ﹤0.01% 4263
2021
Q4 		$4K Sell
800
-47,300
-98% -$1.9M ﹤0.01% 4332
2021
Q3 		$11K Sell
48,100
-17,000
-26% -$617K ﹤0.01% 3833
2021
Q2 		$84K Sell
65,100
-28,700
-31% -$1.06M ﹤0.01% 2026
2021
Q1 		$186K Sell
93,800
-900
-1% -$40.5K 0.01% 1325
2020
Q4 		$320K Buy
94,700
+63,100
+200% +$2.9M 0.02% 840
2020
Q3 		$117K Buy
+31,600
New +$1.67M 0.01% 1223

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Cutler Group's GDRX Position: Q1 2024 in Review

Cutler Group reduced its GoodRx Holdings (GDRX) stake by 92% in Q1 2024, selling an estimated $4.19K and leaving 57 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Cutler Group first reported a position in GDRX in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.5M in Q1 2021. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

  • Cutler Group held 57 shares of GoodRx Holdings worth $0 as of Q1 2024.
  • Cutler Group sold 633 GoodRx Holdings shares in Q1 2024, an estimated $4.19K.
  • GoodRx Holdings made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #2727 holding.
  • Cutler Group first reported a position in GoodRx Holdings in Q3 2020 and has held it in 14 quarters since.
  • Cutler Group's GoodRx Holdings position peaked at $1.5M in Q1 2021.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.